|
|
|
01.05.25 - 22:03
|
Cerus Corporation Announces First Quarter 2025 Financial Results (Business Wire)
|
|
First quarter 2025 Product Revenue of $43.2 Million, Up 13% Over Prior Year
Reiterating Full-Year 2025 Product Revenue Guidance Range of $194 - $200 Million
First Quarter 2025 Total Revenue of $48.9 Million Including Government Contract Revenue of $5.6 Million
Conference Call Today at 4:30 pm ET
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today financial results for the first quarter ended March 31, 2025, and provided a business update.
“We are off to a strong start in 2025, executing against our stated goals and making meaningful progress in advancing Cerus' mission to transform the safety and availability of transfused blood components,” said William “Obi” Greenman, Cerus' president and chief executive officer. “We delivered 13% first quarter product revenue growth, in-line with our Q1 guidance, received CE Mark for the INT200, our next generation LED-based illumination device ahead of plan, and most recently, we have submitted our updated CE Mark application...
|
|
|
17.04.25 - 14:33
|
Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025 (Business Wire)
|
|
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2025 financial results will be released on Thursday, May 1, 2025, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company's financial results and provide a general business overview and outlook.
To listen to the live webcast and view the presentation slides, please visit the Investor Relations page of the Cerus website at http://ir.cerus.com. Participants may register for the call here. While not required, interested participants are encouraged to join 10 minutes prior to the start of the event.
A replay will be available on Cerus' website and will be available approximately three hours after the call through May 22, 2025.
ABOUT CERUS
Cerus Corporation is dedicated solely to safeguarding the world's blood supply and aims to become the preeminent global blood products company. Headquarte...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|